Cargando…
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study
BACKGROUND: Survival rates after childhood cancer now reach nearly 80% in developed countries. However, treatments that lead to survival and cure can cause serious adverse effects with lifelong negative impacts on survivor quality of life. Hearing impairment is a common adverse effect in children tr...
Autores principales: | Clemens, Eva, Meijer, Annelot JM, Broer, Linda, Langer, Thorsten, van der Kooi, Anne-Lotte LF, Uitterlinden, André G, de Vries, Andrica, Kuehni, Claudia E, Garrè, Maria L, Kepak, Tomas, Kruseova, Jarmila, Winther, Jeanette F, Kremer, Leontien C, van Dulmen-den Broeder, Eline, Tissing, Wim JE, Rechnitzer, Catherine, Kenborg, Line, Hasle, Henrik, Grabow, Desiree, Parfitt, Ross, Binder, Harald, Carleton, Bruce C, Byrne, Julianne, Kaatsch, Peter, am Zehnhoff-Dinnesen, Antoinette, Zolk, Oliver, van den Heuvel-Eibrink, Marry M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444213/ https://www.ncbi.nlm.nih.gov/pubmed/30888333 http://dx.doi.org/10.2196/11868 |
Ejemplares similares
-
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset
por: Langer, Thorsten, et al.
Publicado: (2020) -
Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE
por: Calaminus, Gabriele, et al.
Publicado: (2021) -
Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol
por: van der Kooi, Anne-Lotte L. F., et al.
Publicado: (2018) -
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE)
por: van den Berg, Marleen, et al.
Publicado: (2018) -
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
por: Meijer, A. J. M., et al.
Publicado: (2021)